Ads
related to: side effects of perjeta infusion for prostate cancer- Find an Imaging Site
Locate the nearest imaging site
or contact customer service.
- Contact Us
Contact our representatives
for product and reimbursement info.
- Sign Up for Updates
Sign up to receive the latest data,
case studies, and resources.
- Case Studies
Review real case studies
with real patients.
- Find an Imaging Site
Search results
Results from the WOW.Com Content Network
Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer. [4] Side effects in more than half the people taking it include ...
Perjeta: mab: humanized: HER2/neu: Y: cancer Pexelizumab [17] scFv: humanized: C5: reduction of side effects of cardiac surgery: Pidilizumab [40] mab: humanized: PD-1: cancer and infectious diseases Pinatuzumab vedotin [40] mab: humanized: CD22: cancer Pintumomab: mab: mouse: adenocarcinoma antigen: adenocarcinoma (imaging) Placulumab [15] mab ...
As of August 2014, a clinical trial administering sipuleucel-T in conjunction with ipilimumab (Yervoy) was tracking subjects but no longer enrolling new subjects; the trial evaluates the clinical safety and anti-cancer effects (quantified in PSA, radiographic and T cell response) of the combination therapy in patients with advanced prostate cancer.
Patients received treatment until either the cancer progressed or the side effects became intolerable. [18] The study was designed to measure progression-free survival, the length of time patients lived without the cancer progressing, and overall survival, the length of time patients lived before death.
[33] [34] The phase 3 clinical trials also reported infusion related reactions, amyloid-related imaging abnormalities and headaches as the most common side effects of Lecanemab. In July 2023 the FDA gave Lecanemab full approval for the treatment of Alzheimer's Disease [ 35 ] and it was given the commercial name Leqembi.
Prostate cancer is a major topic of ongoing research. From 2016–2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [122] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost. [123]
Ads
related to: side effects of perjeta infusion for prostate cancer